Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management

Abroad (travel likely)Recruiting

Conditions

Diabetic Foot Ulcer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

DPMG, Palm Springs, California, United States
Contact: Study coordinator (Dario Kuzmanovic, MHSc) · dario.kuzmanovic@dpmghealth.com · 909-547-7178
Contact: Principal Investigator (Gemma Kim, MD)
Center for Clinical Research Inc., San Francisco, California, United States
Contact: Study coordinator (Gayana Sarkisova) · gayana@ccr-trials.com · 800-363-1069
Contact: Principal Investigator (Alexander Reyzelman, DPM)
ILD Research Center, Vista, California, United States
Contact: Principal Investigator (Dean J. Vayser, DPM)
Stamford Health Medical Group, Darien, Connecticut, United States
Contact: Study coordinator (Kaila Lasher) · klasher@stamhealth.org · 203-276-4787
Contact: Principal Investigator (Rachel Albright, DPM, MPH)
Optimum Care Research Center, Pembroke Pines, Florida, United States
Contact: Study coordinator (Daniel Moran) · d.moran@optimumcareresearch.com · 954-854-5485
Contact: Principal Investigator (Ronoel Penalver, MD)
Rosalind Franklin University of Medicine and Science, Chicago, Illinois, United States
Contact: Study coordinator (Jacque Ortiz) · jacquelin.ortiz@rosalindfranklin.edu · 847-578-8243
Contact: Principal Investigator (Stephanie Wu, DPM)
Chesapeake Research Group, Pasadena, Maryland, United States
Contact: Study coordinator (Samantha Mallicote) · smallicote@crgmd.com · 410-761-0115
Contact: Principal Investigator (Ira J Gottlieb, DPM)
Oregon Health & Science University, Portland, Oregon, United States
Contact: Study coordinator (Melanie Abrahamson-Sommer) · abrahamm@ohsu.edu · 917-610-3005
Contact: Principal Investigator (Cyyandi Dove, DPM)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)

Diabetic Foot Ulcer

Abroad (travel likely)RecruitingPHASE4

Santa Rosa, United States · Jacksonville, United States

A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers

Diabetic Foot Ulcer

Abroad (travel likely)Recruiting

Clevland, United States

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

Venous Leg Ulcer · Venous Leg · Diabetic Foot

Abroad (travel likely)RecruitingPHASE4

Monroeville, United States

CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs

Wound, Foot · Diabetic Foot Ulcer (DFU) · Venus Leg Ulcer

Abroad (travel likely)Recruiting

San Diego, United States · Coral Gables, United States